Roivant Sciences Ltd. (ROIV)
USD 9.0
(-4.86%)
USD 9.0
(-4.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.18 Billion USD | 5.64% |
| 2023 | -4.13 Billion USD | -10.52% |
| 2022 | 1.22 Billion USD | 153.39% |
| 2021 | 1.39 Billion USD | -17.11% |
| 2020 | 1.09 Billion USD | -20.16% |
| 2019 | 598.98 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 1.18 Billion USD | 5.64% |
| 2024 Q1 | 281.32 Million USD | -40.45% |
| 2024 Q2 | 296.33 Million USD | 100.85% |
| 2024 Q3 | 320.99 Million USD | 8.32% |
| 2024 Q4 | 290.51 Million USD | -9.5% |
| 2023 Q1 | 284.9 Million USD | 3.96% |
| 2023 FY | 1.12 Billion USD | -10.52% |
| 2023 Q4 | 257.36 Million USD | -12.4% |
| 2023 Q3 | 293.79 Million USD | 1.43% |
| 2023 Q2 | 289.65 Million USD | 1.67% |
| 2022 Q4 | 274.05 Million USD | 1.88% |
| 2022 FY | 1.25 Billion USD | 153.39% |
| 2022 Q3 | 268.98 Million USD | -61.13% |
| 2022 Q2 | 692.03 Million USD | 328.82% |
| 2022 Q1 | 161.38 Million USD | 497.19% |
| 2021 Q1 | 115.84 Million USD | -3.14% |
| 2021 Q2 | 157.14 Million USD | 35.65% |
| 2021 Q4 | -40.63 Million USD | -115.38% |
| 2021 Q3 | 264.13 Million USD | 68.08% |
| 2021 FY | 496.5 Million USD | -17.11% |
| 2020 Q4 | 119.6 Million USD | 0.0% |
| 2020 FY | 598.98 Million USD | -20.16% |
| 2019 FY | 750.2 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -332.064% |
| Alkermes plc | 996.24 Million USD | -19.366% |
| Agenus Inc. | 78.18 Million USD | -1421.02% |
| Aptorum Group Limited | 10.56 Thousand USD | -11254670.017% |
| Ardelyx, Inc. | 169.93 Million USD | -599.776% |
| Dyadic International, Inc. | 9.15 Million USD | -12892.664% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -5243.904% |
| Lantern Pharma Inc. | 17.87 Million USD | -6551.793% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -17564.719% |
| Novavax, Inc. | 779.12 Million USD | -52.63% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -1366.999% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -1346.76% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -6023.944% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -3916.682% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -2138.396% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -212.534% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -4792.41% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -3040.244% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -3764.61% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -1303.724% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -6712.047% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -606.012% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -3534.966% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -644.228% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 33.937% |
| AlloVir, Inc. | 180.93 Million USD | -557.248% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -166.789% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -3906.398% |
| Bicycle Therapeutics plc | 216.92 Million USD | -448.206% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -591.777% |
| ChromaDex Corporation | 56.37 Million USD | -2009.259% |
| Chimerix, Inc. | 93.38 Million USD | -1173.361% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -8449.315% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -689.963% |
| CRISPR Therapeutics AG | 463.49 Million USD | -156.568% |
| Precision BioSciences, Inc. | 92.46 Million USD | -1186.113% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -368.1% |
| Fortress Biotech, Inc. | 200.19 Million USD | -494.01% |
| Fortress Biotech, Inc. | 200.19 Million USD | -494.01% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -3531.524% |
| ImmuCell Corporation | 9.61 Million USD | -12264.919% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -653.532% |
| Immix Biopharma, Inc. | 16.14 Million USD | -7267.392% |
| Incyte Corporation | 1.19 Billion USD | 0.111% |
| Innoviva, Inc. | 132.15 Million USD | -799.843% |
| IO Biotech, Inc. | 91.44 Million USD | -1200.459% |
| Jaguar Health, Inc. | 42.01 Million USD | -2730.368% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -602.505% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -1310.266% |
| ContextLogic Inc. | 387 Million USD | -207.281% |
| MiMedx Group, Inc. | 229.72 Million USD | -417.649% |
| MEI Pharma, Inc. | 34.78 Million USD | -3318.655% |
| NextCure, Inc. | 67.63 Million USD | -1658.178% |
| Onconetix, Inc. | 34.9 Million USD | -3306.664% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -9229.821% |
| Opthea Limited | 191.96 Million USD | -519.469% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -43117.963% |
| Vaxcyte, Inc. | 468.04 Million USD | -154.076% |
| PDS Biotechnology Corporation | 43.04 Million USD | -2662.626% |
| Precigen, Inc. | 84.18 Million USD | -1312.645% |
| Pharming Group N.V. | 225.49 Million USD | -427.373% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -608.574% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -1538.755% |
| PureTech Health plc | 144.59 Million USD | -722.409% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -812.906% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -385.066% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -4792.41% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -420.019% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -3753.589% |
| Acelyrin, Inc. | 422.06 Million USD | -181.753% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -9222631.503% |
| Summit Therapeutics Inc. | 87.68 Million USD | -1256.179% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -3108.448% |
| Senti Biosciences, Inc. | 94.7 Million USD | -1155.667% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -862.485% |
| Elevation Oncology, Inc. | 45.44 Million USD | -2516.743% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -3935.356% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -30066.528% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -799.7% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -3388.863% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -13971.459% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -555.914% |
| Seer, Inc. | 110.49 Million USD | -976.277% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -1584.533% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -1172.149% |
| ESSA Pharma Inc. | 32.13 Million USD | -3600.676% |
| GlycoMimetics, Inc. | 39.28 Million USD | -2927.034% |
| GT Biopharma, Inc. | 13.57 Million USD | -8659.421% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -440.954% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -491.293% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -358.39% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1995.137% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -2098.926% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -11866.407% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -194.67% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -6182.313% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -2245.845% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -357.977% |
| Aptose Biosciences Inc. | 52.35 Million USD | -2171.333% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -8152.242% |
| Soligenix, Inc. | 7.79 Million USD | -15155.173% |
| Century Therapeutics, Inc. | 56.07 Million USD | -2020.845% |
| Kura Oncology, Inc. | 165.8 Million USD | -617.22% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -938.521% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -14194.735% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -47819.097% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -1004.179% |
| Autolus Therapeutics plc | 196.72 Million USD | -504.485% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -1304.703% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -921.166% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -6035.165% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -269.588% |
| GRI Bio, Inc. | 11.33 Million USD | -10395.843% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -16754.158% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -806.435% |
| IGM Biosciences, Inc. | 265.59 Million USD | -347.748% |
| INmune Bio, Inc. | 29.89 Million USD | -3877.719% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -589.163% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2849.769% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -7341.968% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -7454.394% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1815.004% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -1005.987% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -331.342% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -294.485% |
| Verastem, Inc. | 92.08 Million USD | -1191.407% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -6529.015% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -540.29% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -879.498% |
| Histogen Inc. | 14.27 Million USD | -8232.252% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -7310.073% |
| Surrozen, Inc. | 18.55 Million USD | -6310.668% |
| Organovo Holdings, Inc. | 14.91 Million USD | -7873.041% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -23261.962% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1892.821% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -4536.718% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -2429.845% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -15479.765% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -567.568% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -2354.549% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -385.371% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -7638.739% |
| Apollomics, Inc. | 54.14 Million USD | -2096.489% |
| Amarin Corporation plc | 272.35 Million USD | -336.625% |
| Mesoblast Limited | 5.9 Million USD | -20048.746% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1418.01% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -387.125% |
| Synaptogenix, Inc. | 8.31 Million USD | -14203.583% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -8052.879% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -369.927% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -3467.886% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -13365.602% |
| Exelixis, Inc. | 1.58 Billion USD | 25.057% |
| Better Therapeutics, Inc. | 38.26 Million USD | -3007.99% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -412.467% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -39.052% |
| NLS Pharmaceutics AG | 11.8 Million USD | -9971.76% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -14687.278% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -3864.855% |
| Gritstone bio, Inc. | 148.37 Million USD | -701.474% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1626.927% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -7168.723% |
| Avid Bioservices, Inc. | 25.99 Million USD | -4474.469% |
| Insmed Incorporated | 949.26 Million USD | -25.274% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -7479.318% |
| MediWound Ltd. | 18.86 Million USD | -6202.623% |
| OmniAb, Inc. | 83.89 Million USD | -1317.461% |
| Alector, Inc. | 248.8 Million USD | -377.962% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -407.528% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -2175.897% |
| Zai Lab Limited | 547.47 Million USD | -117.211% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -198.299% |
| Aura Biosciences, Inc. | 84.99 Million USD | -1299.182% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -381.18% |
| Immunic, Inc. | 99.22 Million USD | -1098.491% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -647.855% |
| Veracyte, Inc. | 357.93 Million USD | -232.235% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 86.81% |
| FibroGen, Inc. | 398.11 Million USD | -198.704% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -8268.607% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -17164.636% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -16588.517% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 63.473% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -4496.216% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -275.677% |
| TG Therapeutics, Inc. | 198.47 Million USD | -499.158% |
| Galecto, Inc. | 35.62 Million USD | -3237.859% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -2822.606% |
| Fortrea Holdings Inc. | 457.3 Million USD | -160.044% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -2090.904% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -4017.941% |
| XBiotech Inc. | 37.51 Million USD | -3070.299% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -1626.927% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -5659.015% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -737.09% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -1100.282% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -974.081% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -24.099% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -4022.652% |
| Vaxxinity, Inc. | 56.05 Million USD | -2021.602% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -176.142% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -5230.654% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -972.618% |
| NexImmune, Inc. | 28.16 Million USD | -4121.811% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -21400.455% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -6546.239% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 57.76% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -4570.957% |
| Scopus BioPharma Inc. | 11.71 Million USD | -10051.016% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -835.905% |
| Ainos, Inc. | 12.95 Million USD | -9080.961% |
| Pluri Inc. | 22.48 Million USD | -5189.942% |
| Prothena Corporation plc | 282.4 Million USD | -321.088% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -494.524% |
| Celularity Inc. | 215.05 Million USD | -452.957% |
| Rallybio Corporation | 78.93 Million USD | -1406.587% |
| Cue Biopharma, Inc. | 19.54 Million USD | -5985.247% |
| MeiraGTx Holdings plc | 151.07 Million USD | -687.129% |
| Omeros Corporation | 94.75 Million USD | -1155.057% |
| Humacyte, Inc. | 23.49 Million USD | -4960.982% |
| Immunocore Holdings plc | 308.04 Million USD | -286.047% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -34979.027% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -1268.997% |
| Blueprint Medicines Corporation | 722.86 Million USD | -64.51% |
| CalciMedica, Inc. | 21.81 Million USD | -5350.699% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1492.793% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -640.737% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -594.229% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -303.194% |
| Pulmatrix, Inc. | 22.03 Million USD | -5296.039% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -3339.419% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -1238.171% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -115.6% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -1539.094% |
| Cytokinetics, Incorporated | 173.61 Million USD | -584.964% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -3355.007% |
| Nutriband Inc. | 5.73 Million USD | -20638.971% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -2626.662% |
| Vor Biopharma Inc. | 126.03 Million USD | -843.523% |
| Evogene Ltd. | 27.79 Million USD | -4179.162% |
| ProKidney Corp. | 151.52 Million USD | -684.823% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1503.207% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -15359.459% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -93.606% |
| CorMedix Inc. | 48.95 Million USD | -2328.988% |
| BioLineRx Ltd. | 50.8 Million USD | -2240.811% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -689.104% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -3023.5% |
| Atai Life Sciences N.V. | 125.78 Million USD | -845.406% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -1356.626% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -1360.746% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -370.865% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -3532.19% |
| MediciNova, Inc. | 10.9 Million USD | -10809.634% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -823.132% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -16280.95% |
| GeoVax Labs, Inc. | 6.02 Million USD | -19646.676% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -149.639% |
| Biomea Fusion, Inc. | 126.13 Million USD | -842.783% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 9.35% |
| Mereo BioPharma Group plc | 35.84 Million USD | -3217.837% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -522.317% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -417.138% |
| Absci Corporation | 73.66 Million USD | -1514.285% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -4211.431% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -790.171% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -391.068% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -353.802% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -471.737% |
| Allakos Inc. | 196.05 Million USD | -506.551% |
| Imunon, Inc. | 20.31 Million USD | -5755.018% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -948.021% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -222.61% |
| BioAtla, Inc. | 129.68 Million USD | -816.961% |
| NLS Pharmaceutics AG | 11.8 Million USD | -9971.76% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -7406.022% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -1300.385% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -2747.787% |
| XOMA Corporation | 46.46 Million USD | -2459.411% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -969.685% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -734.728% |
| aTyr Pharma, Inc. | 12.97 Million USD | -9062.331% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -1047.236% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -587.904% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -366.777% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -3078.943% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -14358.43% |
| Akari Therapeutics, Plc | 16.8 Million USD | -6975.919% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -52195.281% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -297.296% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -17573.157% |
| UroGen Pharma Ltd. | 138.88 Million USD | -756.214% |
| Sutro Biopharma, Inc. | 243 Million USD | -389.356% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -16246.952% |
| Orgenesis Inc. | 45.75 Million USD | -2498.901% |
| Entera Bio Ltd. | 8.86 Million USD | -13321.885% |
| GH Research PLC | 41.22 Million USD | -2784.816% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -4525.716% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -1331.831% |
| Xencor, Inc. | 306.97 Million USD | -287.384% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -24003.648% |
| Replimune Group, Inc. | 234.77 Million USD | -406.523% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -5703.736% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -520.023% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -17573.157% |
| Portage Biotech Inc. | 18.19 Million USD | -6434.31% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -16280.95% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -1032.972% |
| OncoCyte Corporation | 25.63 Million USD | -4538.526% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -19408.787% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -10279.442% |
| Purple Biotech Ltd. | -22.46 Million USD | 5393.003% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -7115.892% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1724.51% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -13968.569% |
| HilleVax, Inc. | 133.34 Million USD | -791.806% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -11462.265% |
| Tharimmune, Inc. | 9.45 Million USD | -12476.957% |
| Genprex, Inc. | 31.06 Million USD | -3728.581% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -534.141% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -3689.97% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -155348.235% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -21732.14% |
| OKYO Pharma Limited | 8243.57 USD | -14425434.083% |
| Savara Inc. | 15.74 Million USD | -7452.741% |
| Curis, Inc. | 58.35 Million USD | -1937.836% |
| Daré Bioscience, Inc. | 33.6 Million USD | -3438.233% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -23251.631% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -15838.601% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -4300.781% |
| BeiGene, Ltd. | 3.28 Billion USD | 63.817% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -5863.996% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -138.425% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -673.943% |
| Erasca, Inc. | 141.52 Million USD | -740.261% |
| bluebird bio, Inc. | 240.23 Million USD | -395.013% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -26168.739% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 31.902% |
| DBV Technologies S.A. | 92.16 Million USD | -1190.342% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -26168.739% |
| Moderna, Inc. | 6.39 Billion USD | 81.402% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -2690.91% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -8177.732% |
| Molecular Templates, Inc. | 63.09 Million USD | -1784.863% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -1682.85% |
| Travere Therapeutics, Inc. | 472 Million USD | -151.944% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -729.789% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1815.497% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -2639.16% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -471.364% |
| MacroGenics, Inc. | 217.21 Million USD | -447.466% |
| RenovoRx, Inc. | 11.39 Million USD | -10335.056% |
| Adicet Bio, Inc. | 152.03 Million USD | -682.159% |
| Prime Medicine, Inc. | 186.63 Million USD | -537.155% |
| Aditxt, Inc. | 25.95 Million USD | -4482.443% |
| Adagene Inc. | 41.83 Million USD | -2742.793% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -16167.62% |
| Quantum-Si incorporated | 111.65 Million USD | -965.01% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -591.987% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -8057.483% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -3219.689% |
| SciSparc Ltd. | 9.01 Million USD | -13096.97% |
| Vericel Corporation | 142.04 Million USD | -737.214% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -13637.151% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -5050.504% |
| Generation Bio Co. | 144.46 Million USD | -723.149% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -1332.228% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -1275.409% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -302.13% |
| Invivyd, Inc. | 205.75 Million USD | -477.959% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -1547.998% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -12579.837% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1480.22% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -11460.017% |
| 2seventy bio, Inc. | 289.88 Million USD | -310.222% |
| ADMA Biologics, Inc. | 66.58 Million USD | -1685.929% |
| Clene Inc. | 41.07 Million USD | -2795.282% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -9184.741% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -2070.193% |
| GeoVax Labs, Inc. | 6.02 Million USD | -19646.676% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -237.789% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -3137.445% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -3425.792% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -1046.727% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -3549.02% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -598.375% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -54.897% |
| Evaxion Biotech A/S | 22.27 Million USD | -5239.825% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -777.338% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -406.288% |
| Trevena, Inc. | 38.41 Million USD | -2995.772% |
| Surrozen, Inc. | 18.55 Million USD | -6310.668% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -1387.496% |
| Cingulate Inc. | 22.75 Million USD | -5125.05% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 15972.651% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -2562.321% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -14342.404% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -1059.519% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -57.698% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1815.744% |
| Clearmind Medicine Inc. | 8.74 Million USD | -13504.066% |
| Kronos Bio, Inc. | 128.11 Million USD | -828.19% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -1314.477% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -40445.008% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -1079.425% |
| Statera Biopharma, Inc. | 28.82 Million USD | -4024.868% |
| ImmunityBio, Inc. | 362.87 Million USD | -227.713% |
| Korro Bio, Inc. | 84.53 Million USD | -1306.746% |
| Kineta, Inc. | 21.15 Million USD | -5521.001% |
| BioVie Inc. | 31.95 Million USD | -3621.976% |
| Codexis, Inc. | 66.51 Million USD | -1687.755% |
| Celularity Inc. | 215.05 Million USD | -452.957% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -424.744% |
| Celcuity Inc. | 66.23 Million USD | -1695.52% |
| Virax Biolabs Group Limited | 6.54 Million USD | -18063.549% |
| Cibus, Inc. | 320.3 Million USD | -271.265% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -2665.533% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -3413.707% |
| IN8bio, Inc. | 30.33 Million USD | -3819.896% |
| Kodiak Sciences Inc. | 277.32 Million USD | -328.81% |
| Annexon, Inc. | 143.72 Million USD | -727.41% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -832.024% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -5090.881% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -185709.219% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -52.54% |
| Eyenovia, Inc. | 25.4 Million USD | -4580.619% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -747.507% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -21280.421% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -1402.76% |
| Arcellx, Inc. | 200.19 Million USD | -493.998% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -2490.804% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -449.5% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -11843.146% |
| Moolec Science SA | 52.75 Million USD | -2154.342% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1845.073% |
| Geron Corporation | 70.44 Million USD | -1588.192% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -2455.176% |
| Royalty Pharma plc | 862.4 Million USD | -37.891% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -1164.116% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -12648.672% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -5155.219% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -472.238% |
| Humacyte, Inc. | 23.49 Million USD | -4960.982% |
| Structure Therapeutics Inc. | 102.77 Million USD | -1057.07% |
| 89bio, Inc. | 151.2 Million USD | -686.473% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -1384.025% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -8078.673% |
| Genelux Corporation | 24.33 Million USD | -4786.702% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -3405.524% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -587.908% |
| Notable Labs, Ltd. | 14.77 Million USD | -7951.313% |
| Liquidia Corporation | 87.98 Million USD | -1251.586% |
| Mustang Bio, Inc. | 48.5 Million USD | -2351.865% |
| Immunovant, Inc. | 282.7 Million USD | -320.637% |
| Quantum-Si incorporated | 111.65 Million USD | -965.01% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -5174.925% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -5491.663% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -1065.725% |
| Acasti Pharma Inc. | 11.3 Million USD | -10422.777% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -5088.14% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -7341.968% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -2455.066% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -104712.265% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -7385.704% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -3978.537% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -2773.524% |
| PepGen Inc. | 84.76 Million USD | -1302.896% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -3913.294% |
| United Therapeutics Corporation | 885.1 Million USD | -34.355% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -5093.602% |
| Solid Biosciences Inc. | 104.31 Million USD | -1039.988% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -3533.796% |
| Immuneering Corporation | 58.41 Million USD | -1935.816% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -23261.962% |
| Silo Pharma, Inc. | 3.92 Million USD | -30221.843% |
| Belite Bio, Inc | 31.66 Million USD | -3655.144% |
| XOMA Corporation | 46.46 Million USD | -2459.411% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -1660.443% |
| Bionomics Limited | 17.89 Billion USD | 93.354% |
| Apogee Therapeutics, Inc. | 93 Million USD | -1178.646% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 3432.901% |
| uniQure N.V. | 285.08 Million USD | -317.13% |
| Cassava Sciences, Inc. | 105.95 Million USD | -1022.322% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -16167.62% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -512.326% |
| Forte Biosciences, Inc. | 32.47 Million USD | -3561.604% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -14212.361% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -3945.515% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -21280.421% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -8268.607% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -13278.097% |
| Altimmune, Inc. | 30.55 Million USD | -3791.802% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -178.072% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 3432.901% |
| Compugen Ltd. | 43.97 Million USD | -2604.462% |
| Peak Bio, Inc. | 1249.13 USD | -95200479.603% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1504.397% |
| Benitec Biopharma Inc. | 22.38 Million USD | -5213.104% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -388.994% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -4066.272% |
| Zura Bio Limited | 62.63 Million USD | -1798.495% |
| PolyPid Ltd. | 21.04 Million USD | -5550.649% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -7206.334% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -4066.272% |
| Instil Bio, Inc. | 85.78 Million USD | -1286.232% |
| argenx SE | 1.53 Billion USD | 22.455% |
| Immunome, Inc. | 122.82 Million USD | -868.229% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -2353.281% |
| Verona Pharma plc | 67.15 Million USD | -1670.896% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -4494.085% |
| Shattuck Labs, Inc. | 93.61 Million USD | -1170.3% |
| CervoMed Inc. | 14.95 Million USD | -7850.244% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -1581.936% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -13818.294% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -2231.724% |
| Moolec Science SA | 52.75 Million USD | -2154.342% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -7129.737% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -797.12% |
| AnaptysBio, Inc. | 181.56 Million USD | -554.95% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1420.884% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -1266.229% |
| NeurAxis, Inc. | 8.82 Million USD | -13380.922% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -9349.178% |
| Lumos Pharma, Inc. | 38.66 Million USD | -2975.595% |
| Achilles Therapeutics plc | 75.25 Million USD | -1480.199% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -4494.085% |
| 180 Life Sciences Corp. | 13.47 Million USD | -8723.439% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -4387.054% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -40445.008% |
| Nutriband Inc. | 5.73 Million USD | -20638.971% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -973.46% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -2036.774% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -2237.269% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -1699.088% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -2097.175% |
| Palisade Bio, Inc. | 13.32 Million USD | -8827.77% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -2518.818% |
| Beam Therapeutics Inc. | 554.19 Million USD | -114.578% |
| Neurogene Inc. | 55.58 Million USD | -2039.465% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -378.564% |
| AEON Biopharma, Inc. | 48.42 Million USD | -2355.51% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -1129.634% |
| Sesen Bio, Inc. | 78.38 Million USD | -1417.178% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -1323.672% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -9347.754% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -163.68% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -1253.031% |
| Athira Pharma, Inc. | 125.46 Million USD | -847.81% |
| Vaccinex, Inc. | 23.45 Million USD | -4970.045% |
| HCW Biologics Inc. | 21.02 Million USD | -5555.346% |
| XOMA Corporation | 46.46 Million USD | -2459.411% |
| Nektar Therapeutics | 190.9 Million USD | -522.923% |
| Arvinas, Inc. | 480 Million USD | -147.746% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -52195.281% |
| Merus N.V. | 200.49 Million USD | -493.124% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -1050.577% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -3334.948% |
| Rezolute, Inc. | 70.38 Million USD | -1589.487% |
| Clene Inc. | 41.07 Million USD | -2795.282% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -7160.621% |
| BeyondSpring Inc. | 24.86 Million USD | -4682.542% |
| Synlogic, Inc. | 58.53 Million USD | -1931.673% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -6546.429% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -26373.264% |
| Peak Bio, Inc. | 1249.13 USD | -95200479.603% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1867.341% |
| Krystal Biotech, Inc. | 160.42 Million USD | -641.263% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -339.41% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -241.681% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -55037.954% |
| MannKind Corporation | 125.59 Million USD | -846.821% |
| Ikena Oncology, Inc. | 84.57 Million USD | -1306.031% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -12226.931% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -1227.194% |
| Gossamer Bio, Inc. | 183.75 Million USD | -547.141% |
| CohBar, Inc. | 12.38 Million USD | -9499.213% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -2244.411% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -4211.431% |
| Legend Biotech Corporation | 583.14 Million USD | -103.925% |
| Mural Oncology plc | 192.07 Million USD | -519.135% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -1671.008% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -7265.494% |
| Disc Medicine, Inc. | 91.12 Million USD | -1204.998% |
| Champions Oncology, Inc. | 28.11 Million USD | -4130.448% |
| REGENXBIO Inc. | 321.15 Million USD | -270.28% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -22081.069% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -2032.827% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -2952.257% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -939.883% |
| Vaxart, Inc. | 90.72 Million USD | -1210.737% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -13857.487% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -2678.84% |
| Cellectis S.A. | 97.32 Million USD | -1121.927% |
| Longeveron Inc. | 21.25 Million USD | -5496.136% |
| Repare Therapeutics Inc. | 167.35 Million USD | -610.564% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 12.613% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1472.052% |
| Revolution Medicines, Inc. | 498.76 Million USD | -138.425% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -17777.014% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -2605.508% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1494.287% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -1607.732% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -10652.071% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 75.096% |
| Denali Therapeutics Inc. | 527.23 Million USD | -125.552% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -13637.151% |
| Veru Inc. | 101.34 Million USD | -1073.36% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -4980.442% |
| Cingulate Inc. | 22.75 Million USD | -5125.05% |
| Passage Bio, Inc. | 108.38 Million USD | -997.14% |
| Context Therapeutics Inc. | 25.07 Million USD | -4642.939% |
| Exicure, Inc. | 14.07 Million USD | -8348.274% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -477.092% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -2646.308% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -12857.845% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -370.994% |
| Nuvalent, Inc. | 149.49 Million USD | -695.48% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -14641.458% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -1047.302% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -5444.217% |
| OmniAb, Inc. | 83.89 Million USD | -1317.461% |
| Anew Medical, Inc. | 1.3 Million USD | -91316.168% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -3529.529% |
| Lipocine Inc. | 15.08 Million USD | -7785.73% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -1635.698% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1461.586% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -2849.769% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -935.482% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -5212.63% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -79.054% |
| Ocugen, Inc. | 71.56 Million USD | -1561.63% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -1166.89% |
| Q32 Bio Inc. | 92.68 Million USD | -1183.102% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -5516.223% |
| Alumis Inc. Common Stock | 158.17 Million USD | -651.817% |
| Equillium, Inc. | 50.6 Million USD | -2249.877% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1805.552% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -8451.827% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -6203.59% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -2432.809% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -996.361% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -9495.781% |
| Dominari Holdings Inc. | 23.83 Million USD | -4889.213% |
| Edesa Biotech, Inc. | 9.22 Million USD | -12793.963% |
| vTv Therapeutics Inc. | 11.9 Million USD | -9887.226% |
| Bio-Techne Corporation | 563.03 Million USD | -111.207% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -190.891% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -342.475% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -799.007% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -8151.884% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -626.456% |
| Nkarta, Inc. | 131.65 Million USD | -803.288% |
| BioCardia, Inc. | 12.12 Million USD | -9710.898% |
| Iterum Therapeutics plc | 47.46 Million USD | -2405.222% |